1207 results about "Providing material" patented technology

This invention provides devices, compositions and methods for determining the concentration of one or more metabolites or analytes in a biological sample, including cells, tissues, organs, organisms, and biological fluids. In particular, this invention provides materials, apparatuses, and methods for several non-invasive techniques for the determination of in vivo blood glucose concentration levels based upon the in vivo measurement of one or more biologically active molecules found in skin.

The invention provides materials and methods (including driving methods) for reducing the effects of remnant voltages in electro-optic displays.

The invention provides materials and methods (including driving methods) for reducing the effects of remnant voltages in electro-optic displays.

Sensor platforms and methods of making them are described. A platform having a non-horizontally oriented sensor element comprising one or more nanostructures such as nanotubes is described. Under certain embodiments, a sensor element has or is made to have an affinity for an analyte. Under certain embodiments, such a sensor element comprises one or more pristine nanotubes. Under certain embodiments, the sensor element comprises derivatized or functionalized nanotubes. Under certain embodiments, a sensor is made by providing a support structure; providing one or more nanotubes on the structure to provide material for a sensor element; and providing circuitry to electrically sense the sensor element's electrical characterization. Under certain embodiments, the sensor element comprises pre-derivatized or pre-functionalized nanotubes. Under other embodiments, sensor material is derivatized or functionalized after provision on the structure or after patterning. Under certain embodiments, a large-scale array of sensor platforms includes a plurality of sensor elements.

Provided herein are novel phosphors useful in the manufacture of white light emitting diodes. The phosphors provided by the invention are described by the formula:SrxBayCazSiO4:Euin which x, y, and z are each independently variable to be any value between about 0 and about 2, including without limitation 0.001 and 2, and every thousandth therebetween, subject to the proviso that the sum of x, y, or z is equal to at least 1, and in which Eu is present in any amount between about 0.0001% and about 5% by weight based upon the phosphor's total weight, wherein substantially all of the europium present is present in the divalent state. A phosphor according to the invention may optionally further comprise an element selected from the group consisting of: Ce, Mn, Ti, Pb, and Sn and is present in any amount between about 0.0001% and about 5% by weight based on the phosphor's total weight. The silicate phosphor materials provided by the present invention do not require the addition of dissimilar blue and red phosphor compounds, and do not contain zinc and / or magnesium. In addition, the present invention provides materials which emit a broad yellowish color containing both green and red emissions.Standard techniques used in phosphor deposition for the manufacture of light emitting diodes which comprise phosphors may be employed to produce LED's having a white light output when the phosphors of the invention are utilized.

Materials and methods are provided for producing patterned multi-array, multi-specific surfaces for use in diagnostics. The invention provides for electrochemiluminescence methods for detecting or measuring an analyte of interest. It also provides for novel electrodes for ECL assays. Materials and methods are provided for the chemical and / or physical control of conducting domains and reagent deposition for use multiply specific testing procedures.

The present invention generally provides methods for B-cell reduction in an individual using CD37-specific binding molecules. In particular, the invention provides methods for B-cell reduction using CD37-specific binding molecules alone, or a combination of CD37-specific binding molecules and CD20-specific binding molecules, in some instances a synergistic combination. The invention further provides materials and methods for treatment of diseases involving aberrant B-cell activity. In addition, the invention provides humanized CD37-specific binding molecules.

The present invention relates to the field of molecular diagnostics, and in particular to diagnostics based on a liquid crystal assay format. In particular, the present invention provided improved substrates and methods of using liquid crystal assays for quantitating the amount of an analyte in a sample. The present invention also provides materials and methods for detecting non-specific binding of an analyte to a substrate by using a liquid crystal assay format.